Ohmyhome Nasdaq Deficiency Saga Ends: What Micro-Cap Listing Risk Means for Traders

Event Analysis

Ohmyhome Ltd (OMH), a Singapore-based proptech company listed on the Nasdaq Capital Market, received a minimum bid price deficiency notice from Nasdaq's Listing Qualifications Department on April 30, 2024, after its shares traded below the mandatory US$1.00 per share threshold for 30 consecutive business days — a violation of Nasdaq Listing Rule 5550(a)(2). According to the company's SEC disclosures, Ohmyhome was granted an initial 180-day compliance window through October 28, 2024, followed by a second 180-day extension through April 28, 2025, after failing to cure the deficiency in time.

The matter was formally closed on March 24, 2025, when Nasdaq confirmed OMH had regained compliance after maintaining a closing bid price at or above US$1.00 for 10 consecutive trading days (March 10–21, 2025). However, the compliance journey laid bare a deeply troubled corporate story: OMH executed a one-for-ten reverse stock split, sold its core real estate brokerage unit to a founders' vehicle for US$1, and pivoted entirely to digital marketing — all while shares declined over 98% from the split-adjusted IPO price, per research disclosures. With a market cap of approximately US$15.7 million, OMH sits firmly in distressed micro-cap territory.

What makes this case instructive beyond OMH itself is the regulatory mechanics it exposes. The Nasdaq compliance framework — deficiency → 180-day cure → extension → delisting or cure — is a well-worn path for dozens of small-cap and micro-cap names each year. Tightening Nasdaq and SEC rules around minimum bid price and reverse splits have made this pathway increasingly relevant for the broader universe of thinly traded Nasdaq-listed issuers. Traders who understand this cycle can anticipate volatility inflection points tied to filing dates and compliance milestones.

What This Means for Traders

For OMH specifically, the immediate listing risk has been resolved, but the stock's structural profile remains high-risk. The fundamental business transformation — from proptech to digital marketing, via a US$1 asset sale to insiders — raises persistent concerns around related-party governance, revenue visibility, and whether the listed entity retains any of its original economic substance. Even with compliance regained, the history of repeated deficiency, reverse splits, and insider transactions keeps a delisting risk premium embedded in the stock. Traders should treat OMH as a high-risk special situation requiring tight position sizing.

The broader trading takeaway involves the NASDAQ-100 Index ecosystem and how micro-cap compliance events signal sector-level stress. OMH's saga is idiosyncratic and has no measurable impact on major indices, FX, or commodities. However, it is a useful case study for traders monitoring other small-cap Nasdaq-listed names — particularly Southeast Asian or emerging-market proptech companies — for similar listing-risk dynamics. Event-driven traders can exploit volatility around formal SEC filing dates (deficiency notices, compliance confirmations, reverse split announcements) as these tend to generate outsized intraday moves in thinly traded names. For context on how equity offerings and capital markets mechanics interact with listing compliance, the structural dynamics are closely related.

Start Trading on CoinUnited.io

Create Your Free Account → — Trade crypto, stocks, forex, indices, and commodities with up to 2000x leverage and zero fees.